Reports and Releases
2019/01/18
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
FIT Biotech Oy: FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI rules.
2018/12/21
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/12/14
FIT Biotech Oy: FIT Biotech's financial calendar and Annual General Meeting in 2019
2018/11/27
FIT Biotech Oy: EHVA starts recruiting participants to clinical trial testing FIT Biotech's vaccine
2018/11/12
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2018/10/17
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/10/04
FIT Biotech Oy: FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus
2018/09/27
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2018/09/21
FIT Biotech Oy: RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY SEPTEMBER 21, 2018
2018/09/19
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/09/06
FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2018
2018/08/31
FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY
2018/08/30
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/08/24
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/08/20
FIT Biotech Oy: Correction to company release dated August 16th, 2018: Chairman of the board on leave of absence
2018/08/16
FIT Biotech Oy: FIT Biotech concludes the exploration of secondary listing to First North Sweden -not relevant at the moment
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2018/08/07
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/07/25
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/07/05
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/07/04
CORRECTION FIT Biotech Oy: FIT Biotech's company site has been launched in Inderes.fi
2018/07/02
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2018/06/26
FIT Biotech Oy: EHVA clinical trial authorization granted for testing FIT-06 in UK
2018/06/25
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/06/12
FIT Biotech Oy: First EHVA clinical trial authorization granted for testing FIT-06
2018/05/25
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/05/22
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants - FIT Biotech's own equity positive with draw down of fourth Tranche
2018/05/17
FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of April - FIT Biotech Ltds' equity will be positive with draw down of the fourth tranche
2018/05/11
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
2018/05/07
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/04/27
FIT Biotech Oy: APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH
2018/04/24
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/04/18
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/04/16
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
2018/04/12
FIT Biotech Oy: Resolutions of the Annual General Meeting and the Board of FIT Biotech Oy on April 12, 2018
2018/03/29
CORRECTION: FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2018/03/22
FIT Biotech Oy: Notice Convening the 2018 Annual General Meeting of FIT Biotech Oy
2018/03/21
FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018
2018/03/15
FIT Biotech Oy: FIT Biotech's Review of Operations and Financial Statement 2017 published
2018/03/14
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/03/09
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
2018/03/06
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/03/02
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/03/01
FIT Biotech Oy: FIT BIOTECH OY FINANCIAL STATEMENT BULLETIN JANUARY 1 - DECEMBER 31, 2017
2018/02/26
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - last conversion of Bracknor financing programme
2018/02/22
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/02/21
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
2018/02/19
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/02/14
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing
2018/02/13
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/02/08
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/02/06
FIT Biotech Oy: RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY FEBRUARY 6, 2018
2018/01/31
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
2018/01/29
Correction to company release dated January 26, 2018 - Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - number of shares
2018/01/26
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/01/18
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/01/16
FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY
2018/01/15
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2018/01/10
FIT Biotech Oy: FIT Biotech's EUR 10 million financing agreements' share loan and first part of commitment fee related shares have been handed over today to Alpha Blue Ocean
2018/01/05
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/12/29
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/12/28
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/12/27
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself without payment
2017/12/23
FIT Biotech Oy: FIT Biotech enters into EUR 10 million financing - FIT Biotech's equity back to positive after first tranche financing received
2017/12/01
FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
2017/11/13
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/11/06
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/10/30
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2017/10/25
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/10/18
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/10/16
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/10/09
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/10/06
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/10/05
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/09/26
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/09/19
FIT Biotech: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/09/15
FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017
2017/09/11
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/09/01
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2017/08/28
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/08/23
FIT Biotech Oy: FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board
2017/08/22
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/08/08
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/07/31
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/07/25
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/07/18
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2017/07/12
FIT Biotech Oy: FIT Biotech Receives EUR 644,868 Payment from European HIV Vaccine Alliance (EHVA)
2017/06/13
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2017/06/12
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/05/30
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/05/10
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/05/02
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2017/04/25
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/04/07
FIT Biotech Oy: Resolutions of the Annual General Meeting and the Board of FIT Biotech Oy on April 7, 2017
2017/04/04
FIT Biotech Oy: FIT Biotech has demonstrated proof-of-concept of its gene delivery vector in cancer models
2017/03/31
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
2017/03/24
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into Shares
2017/03/16
FIT Biotech Oy: Notice Convening the 2017 Annual General Meeting of FIT Biotech Oy
2017/03/10
FIT Biotech Oy: FIT BIOTECH OY'S ANNUAL FINANCIAL REPORT JANUARY 1- DECEMBER 31, 2016
FIT Biotech Oy: FIT Biotech Ltd's own equity negative, convertible note loans converted into capital loans
2017/02/28
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2017/01/26
FIT Biotech Oy: FIT Biotech Oy's Extraordinary General Meeting held on January 26th 2017 appointed Eero Rautalahti to the Board of Directors.
2017/01/11
FIT Biotech Oy: FIT Biotech Oy has extended the registration day for the extraordinary General Meeting on January 26, 2017
2017/01/02
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2016/12/16
FIT Biotech Oy: FIT Biotech partners with InnaVirVax for HIV Immunotherapy Clinical Development and Commercialization
2016/11/08
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
2016/10/24
FIT Biotech Oy: Tekes issues a decision on the company's rectification request related to Tekes's claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010
2016/10/14
FIT Biotech Oy: Correction to company release: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
FIT Biotech Oy: Correction to English company release: Conversion of FIT Biotech Oy's Convertible Notes into shares
2016/09/26
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the implementation of financing transactions between the Company and Bracknor Investment and between the Company and Sitra
2016/09/23
FIT Biotech Oy: Tekes issues a partial decision on the company's rectification request related to Tekes's claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010
2016/09/15
FIT Biotech Oy: Resolutions of FIT Biotech Oy's Extraordinary General Meeting on September 15, 2016
2016/09/14
FIT Biotech Oy: FIT BIOTECH OY'S HALF-YEAR FINANCIAL REPORT JANUARY 1-JUNE 30, 2016
2016/09/05
FIT Biotech Oy: FIT Biotech to repeat it's proof-of-concept gene-based treatment study
2016/08/25
FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY
FIT Biotech Oy: FIT Biotech has agreed on a EUR 12,480,000 financing transaction with Bracknor Investment and intends to agree on a EUR 500,000 financing transaction with Sitra
FIT Biotech Oy: FIT Biotech's GMP facility audited and approved - the company resumes manufacturing of drug candidates
2016/07/04
FIT Biotech Oy: FIT BIOTECH PROMOTES LIISA LAITINEN TO SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
2016/06/22
FIT Biotech Oy: Tekes issues a claim to partly reclaim a capital loan related to the FIT Biotech HIV vaccine project in 2009-2010
2016/06/16
FIT Biotech Oy: FIT Biotech expands collaboration with Icosagen in the development of gene-based treatments
2016/06/13
FIT Biotech Oy: FINANCIAL SUPERVISORY AUTHORITY HAS ISSUED A PUBLIC WARNING TO FIT BIOTECH OY
2016/06/10
FIT Biotech Oy: Research grant application related to Innovative Medicines Initiative 2 (IMI2) did not result in a positive decision
2016/06/09
FIT Biotech Oy: FIT Biotech's HIV vaccine demonstrated to be safe and well tolerated in two clinical studies
2016/04/08
FIT Biotech Oy: Resolutions of the Annual General Meeting and the Board of FIT Biotech Oy on April 8, 2016
2016/04/05
FIT Biotech Oy: Finnish FIT Biotech and US Ichor to collaborate on new cost effective infectious disease treatment
2016/03/18
FIT Biotech Oy: Notice Convening the 2016 Annual General Meeting of FIT Biotech Oy
2016/03/11
Fit Biotech Oy: Financial Statements Bulletin of FIT Biotech Oy Jan 1-Dec 31, 2015
2016/03/07
FIT Biotech Oy lowers its profit forecast for the 2016 financial period and has started raising additional finance to ensure the implementation of its business plan and continuity of its business
2016/03/01
FIT Biotech Oy: Liquidity providing agreement between FIT Biotech Oy and FIM Sijoituspalvelut transferred to S-Pankki
2016/02/16
FIT Biotech Oy : Significant preclinical results for FIT Biotech in applying GTU® technology to gene therapy
2016/01/21
FIT Biotech Oy: Changes in FIT Biotech's Management team and Board of Directors
2015/10/22
Resolutions by FIT Biotech Oy's extraordinary general meeting on 22 October 2015 relating to the composition of the board of directors
2015/09/29
FIT Biotech to study further the feasibility of its GTU®-technology in gene therapy
2015/05/29
FIT Biotech Ltd's Board of Directors has decided on a share offering and on an application for the admission of the Company's series K shares to trading on the First North Finland market